CoreAge Rx vs Intimate Rose
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Intimate Rose head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
Intimate Rose
FDA warning letter, September 2025 — issued to Intimate Rose. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 65 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Intimate Rose a bad call — it's best for readers comparing oral compounded options who can obtain a drug-specific quote and understand the subscription before submitting intake. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Intimate Rose |
|---|---|---|
| Brief Score | 94/100 (A) | 65/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm drug-specific quote Shared weight-loss offer from $169/month; oral compounded semaglutide is listed. Consent describes monthly renewal and first charge at intake; cancel at least 72 hours before billing. Full price detailsNamed semaglutide quote unknown; oral compounded program advertised alongside a shared from $169/month weight-loss price |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm drug-specific quote Shared weight-loss offer from $169/month; oral compounded tirzepatide is listed. Consent describes monthly renewal and first charge at intake; cancel at least 72 hours before billing. Full price detailsNamed tirzepatide quote unknown; oral compounded program advertised alongside a shared from $169/month weight-loss price |
| Coverage | US only; restrictions by state, confirmed at intake | Weight-care eligibility depends on the treating provider and patient location; complete current state list unconfirmed. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Intimate Rose: Confirm the drug-specific charge before intake: consent says the first month is charged when intake is completed, with a 72-hour renewal cancellation deadline.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.